A detailed history of Parkman Healthcare Partners LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 260,226 shares of ETON stock, worth $3.24 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
260,226
Previous 253,197 2.78%
Holding current value
$3.24 Million
Previous $833,000 87.39%
% of portfolio
0.22%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.28 - $6.0 $23,055 - $42,174
7,029 Added 2.78%
260,226 $1.56 Million
Q2 2024

Aug 14, 2024

BUY
$3.06 - $3.75 $165,328 - $202,608
54,029 Added 27.13%
253,197 $833,000
Q4 2023

Feb 14, 2024

BUY
$3.45 - $4.66 $117,879 - $159,222
34,168 Added 20.71%
199,168 $872,000
Q3 2023

Nov 14, 2023

BUY
$2.55 - $5.63 $420,749 - $928,950
165,000 New
165,000 $688,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $315M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.